Prevention of Chemotherapy-Induced Neutropenia Using G-CSF with VACOP-B—A Case Report
作者:
AnglinPeter,
StraussBarbara A.,
BrandweinJoseph M.,
期刊:
Leukemia&Lymphoma
(Taylor Available online 1993)
卷期:
Volume 11,
issue 5-6
页码: 469-472
ISSN:1042-8194
年代: 1993
DOI:10.3109/10428199309067942
出版商: Taylor&Francis
关键词: G-CSF;hematopoietic growth factors;neutropenia non-hodgkin's lymphoma;chemotherapy
数据来源: Taylor
摘要:
Hematopoietic growth factors, including granulocyte colony-stimulating factor (G-CSF), are being increasingly used to prevent chemotherapy-induced neutropenia. We report a patient with aggressive non-Hodgkin's lymphoma who was successfully supported with G-CSF through a weekly VACOP-B chemotherapy regimen. The patient had become severely neutropenic at week 3, requiring a one-week delay. For the remainder of the treatment, G-CSF at a dose of 4μg/kg/day was administered daily over 4 days after week 4, then over 3 days thereafter, beginning the day after the non-myelosuppressive weeks (vincristine/bleomycin). A total of 5 such G-CSF courses were given, with no further neutropenia despite administration of full chemotherapy doses on schedule. This case suggests that, at least with the VACOP-B regimen, chemotherapy-induced neutropenia can be prevented using much lower quantities of G-CSF than has been reported using other regimens.
点击下载:
PDF (276KB)
返 回